User profiles for F. Ziemssen
Focke ZiemssenUniversity Leipzig Verified email at medizin.uni-leipzig.de Cited by 7437 |
The role of the humoral immune system in multiple sclerosis (MS) and its animal model experimental autoimmune encephalomyelitis (EAE)
T Ziemssen, F Ziemssen - Autoimmunity reviews, 2005 - Elsevier
… roles of the humoral immune system in MS and EAE: antigen presentation by B cells and
Abs (d); Costimulation to T cells by B cells (e); Myelin opsonization by anti-myelin Abs (f); …
Abs (d); Costimulation to T cells by B cells (e); Myelin opsonization by anti-myelin Abs (f); …
[HTML][HTML] Bevacizumab: off-label use in ophthalmology
S Grisanti, F Ziemssen - Indian journal of ophthalmology, 2007 - journals.lww.com
Bevacizumab is a full-length, humanized monoclonal antibody directed against all the
biologically active isoforms of vascular endothelial growth factor (VEGF-A). The antibody was …
biologically active isoforms of vascular endothelial growth factor (VEGF-A). The antibody was …
[HTML][HTML] Systematic review: non-adherence and non-persistence in intravitreal treatment
C Ehlken, F Ziemssen, N Eter, I Lanzl… - Graefe's Archive for …, 2020 - Springer
Purpose Intravitreal injection of VEGF inhibitors has become the standard of care for different
macular diseases within the last years resulting in improved visual outcomes. Under real-…
macular diseases within the last years resulting in improved visual outcomes. Under real-…
A swarm of slippery micropropellers penetrates the vitreous body of the eye
… (F) Dependence of the propulsion velocity of the slippery micropropellers on the driving
frequency of the magnetic field in the vitreous, 25% glycerol solution, and water, respectively. …
frequency of the magnetic field in the vitreous, 25% glycerol solution, and water, respectively. …
[HTML][HTML] Penetration of bevacizumab through the retina after intravitreal injection in the monkey
…, AF Mack, S Peters, F Ziemssen… - … & visual science, 2007 - arvojournals.org
purpose. The penetration of intravitreally injected bevacizumab in its commercial formulation
(Avastin; Roche, Grenzach, Germany) through the retina was studied, to determine whether …
(Avastin; Roche, Grenzach, Germany) through the retina was studied, to determine whether …
Safety and efficacy of opicinumab in acute optic neuritis (RENEW): a randomised, placebo-controlled, phase 2 trial
…, M Skeen, GJ Jaffe, H Butzkueven, F Ziemssen… - The Lancet …, 2017 - thelancet.com
Background The human monoclonal antibody opicinumab (BIIB033, anti-LINGO-1) has
shown remyelinating activity in preclinical studies. We therefore assessed the safety and …
shown remyelinating activity in preclinical studies. We therefore assessed the safety and …
Intracameral bevacizumab for iris rubeosis
…, S Biester, S Peters, O Tatar, F Ziemssen… - American journal of …, 2006 - Elsevier
PURPOSE: To determine whether intracameral bevacizumab decreases vascular leakage
from iris rubeosis in patients with neovascular glaucoma. DESIGN: Interventional case series. …
from iris rubeosis in patients with neovascular glaucoma. DESIGN: Interventional case series. …
Ultrastructural findings in the primate eye after intravitreal injection of bevacizumab
S Peters, P Heiduschka, S Julien, F Ziemssen… - American journal of …, 2007 - Elsevier
PURPOSE: To examine the ultrastructural effect of intravitreal bevacizumab on primate eyes
with particular focus set on the choriocapillaris and to examine the influence of vascular …
with particular focus set on the choriocapillaris and to examine the influence of vascular …
Safety, penetration and efficacy of topically applied bevacizumab: evaluation of eyedrops in corneal neovascularization after chemical burn
E Yoeruek, F Ziemssen, S Henke‐Fahle… - Acta …, 2008 - Wiley Online Library
… Efdal Yoeruek and Focke Ziemssen are joint first authors of … Efdal Yoeruek and Focke
Ziemssen are joint first authors of … Efdal Yoeruek and Focke Ziemssen are joint first authors of this …
Ziemssen are joint first authors of … Efdal Yoeruek and Focke Ziemssen are joint first authors of this …
Vitreous levels of bevacizumab and vascular endothelial growth factor-A in patients with choroidal neovascularization
Q Zhu, F Ziemssen, S Henke-Fahle, O Tatar… - Ophthalmology, 2008 - Elsevier
PURPOSE: To investigate the vitreous levels of bevacizumab and vascular endothelial
growth factor-A (VEGF-A) after intravitreal injection of the drug in patients with choroidal …
growth factor-A (VEGF-A) after intravitreal injection of the drug in patients with choroidal …